Zobrazeno 1 - 10
of 33
pro vyhledávání: '"drugs costs"'
Autor:
Jorge A. Sánchez-Duque
Publikováno v:
Infectio, Vol 28, Iss 1, Pp 19-26 (2024)
Introduction: Antibiotics are frequently used in intensive care units (ICUs). Objective: To describe the trends of antibiotic use in Colombian ICUs across 8 years.Methods: This was a descriptive study that analyzed the consumption of antibiotics in 1
Externí odkaz:
https://doaj.org/article/2e9858a5d7ce48fd877520e314840c43
Publikováno v:
Analele Universităţii Constantin Brâncuşi din Târgu Jiu : Seria Economie, Iss 4, Pp 282-292 (2022)
Although the COVID-19 pandemic affected the diagnostic and treatment of cancer, it also had a positive impact on the growth of the oncology drugs market globally, with certain market segments registering an increase in demand for drugs with respect
Externí odkaz:
https://doaj.org/article/9858f7b37316449c8a4fa25835f79506
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Marín, Gustavo Horacio, Cañas, Martín, Marín, Gina, Marín, Lupe, Nucher, Daniel, Díaz Pérez, Darío, Urtasun, Martín
Publikováno v:
CIC Digital (CICBA)
Comisión de Investigaciones Científicas de la Provincia de Buenos Aires
instacron:CICBA
Comisión de Investigaciones Científicas de la Provincia de Buenos Aires
instacron:CICBA
Introducción: En Argentina, los medicamentos de alto costo (MAC) generan una carga económica elevada que deben afrontar las instituciones sanitarias. Sin embargo, no existe a la fecha un estudio en Argentina que indique la magnitud del real problem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3056::01ff8c7e8d8f66d7383c50f84bf2e08b
https://digital.cic.gba.gob.ar/handle/11746/11769
https://digital.cic.gba.gob.ar/handle/11746/11769
Autor:
Mikael Hoffmann, Stuart McTaggart, Vanda Marković-Peković, Irene Langner, Skule Ingeberg, Iva Selke Krulichová, Carol Holmes, Juraj Slabý, Brian Godman, Biljana Tubić, Svens Henkuzens, Corinne Zara, Jakub Rutkowski, Jurij Fürst, András Inotai, Stephen Campbell, Konstantin Tachkov, Sean MacBride-Stewart, Ileana Mardare, Mihajlo Jakovljevic, Kristina Garuolienė, Marta Turu Pedrola, Øyvind Melien, Gisbert Selke, Magdalene Wladysiuk, Björn Wettermark, Amanj Kurdi, Arianit Jakupi, Caridad Pontes, Vasileios Kourafalos, Manfred Hinteregger, Eleonora Allocati, Radka Nejezchlebova, Guenka Petrova, Francis Kalemeera, Rita Banzi, András Harsányi, Patricia Vella Bonanno, Ott Laius, Robert Sauermann, Alice Pisana, Jolanta Gulbinovič, Anna Nachtnebel, Iris Hoxha
Publikováno v:
BioMed research international, London : Hindawi Ltd., 2021, vol. 2021, art. no. 9996193, p. [1-16]
BioMed Research International
BioMed Research International, Vol 2021 (2021)
BioMed Research International
BioMed Research International, Vol 2021 (2021)
Background. Diabetes mellitus rates and associated costs continue to rise across Europe enhancing health authority focus on its management. The risk of complications is enhanced by poor glycaemic control, with long-acting insulin analogues developed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1f71eb049d04b088f4f63846e1ca06c
https://repository.vu.lt/VU:ELABAPDB116509835&prefLang=en_US
https://repository.vu.lt/VU:ELABAPDB116509835&prefLang=en_US
Autor:
Miriam Cires Pujol
Publikováno v:
Revista Cubana de Medicina General Integral, Vol 18, Iss 2, Pp 165-168 (2002)
Externí odkaz:
https://doaj.org/article/ac631aecd8ce46409af8a7e88684a346
Autor:
Robert Likić
Publikováno v:
Br J Clin Pharmacol
U ovom editorijalu raspravlja se neodrživost cijena novih i bioloških lijekova te predlažu mjere koje bi omogućile očuvanje funkcioniranja zdravstvenih sustava uz dostupnost novih terapija pacijentima kojima su ti lijekovi potrebni.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a23865b4b25bb437bdb013cfe10da9ce
https://doi.org/10.1111/bcp.14295
https://doi.org/10.1111/bcp.14295